National Cancer Institute funds Wisconsin clinical trial network
Gundersen Health System, Marshfield Clinic Health System and ThedaCare partner to strengthen cancer research program
MARSHFIELD –Wisconsin National Community Oncology Research Program (WiNCORP)-a Wisconsin cancer clinical trial network,- was recently awarded $15.6 million to make the latest treatment options available to people with cancer.
The National Cancer Institute awarded the funds.
WiNCORP is a partnership between Gundersen Health System, Marshfield Clinic Health System and ThedaCare. The partnership provides innovative cancer clinical trials to patients in Wisconsin. This partnership builds upon the collaborative relationship these three health systems have, to improve access to cancer clinical trials for more patients.
This will be the second time WiNCORP has received this award from the National Cancer Institute. During the first 5-year period, about 150 active cancer clinical trials were available at any given time.
“We have participated in hundreds of clinical trials that have made a huge difference to our patients since we received the initial award and are excited that we get to continue to provide our patients with this state-of-the-art cancer care,” said Dr. Adedayo Onitilo, medical director for Cancer Care and Research at Marshfield Clinic Health System and principal investigator for WiNCORP.
Gundersen and Marshfield worked previously with the National Cancer Institute as part of its Community Clinical Oncology Program (CCOP), which preceded NCORP. Marshfield and Gundersen joined CCOP in 1983 and 2011, respectively. ThedaCare joined WiNCORP in 2019.
NCORP is a national NCI-supported network of investigators, cancer care providers, academic institutions and other organizations that provide care to diverse populations in community-based health care practices across the U.S.